2021
DOI: 10.1080/13645706.2020.1866016
|View full text |Cite
|
Sign up to set email alerts
|

A case of maxillary cancer treated by intra-arterial therapy using a steerable microcatheter

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…Our early first-in-human results highlight the ability of the Bendit21 to be navigated through complex vasculature without delays or vessel damage. The acute-angle branching in the internal carotid artery has presented a challenge for catheterization with conventional microcatheters 11 14 15. Likewise, the extradural (V3) curve of the vertebral artery is difficult to reproduce in microcatheters of a fixed shape 3.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Our early first-in-human results highlight the ability of the Bendit21 to be navigated through complex vasculature without delays or vessel damage. The acute-angle branching in the internal carotid artery has presented a challenge for catheterization with conventional microcatheters 11 14 15. Likewise, the extradural (V3) curve of the vertebral artery is difficult to reproduce in microcatheters of a fixed shape 3.…”
Section: Discussionmentioning
confidence: 99%
“…13 Adult patients aged 18 or older who were candidates for intracranial diagnostic vascular imaging or selective therapeutic treatment and gave informed consent were included in the study. Exclusion criteria consisted of the following: (1) pregnant or lactating patients, (2) disorders of vascular fragility (eg, Ehlers-Danlos syndrome), (3) prior vascular dissection or injury to vessels to be catheterized, (4) myocardial infarction or uncontrolled arrhythmia, (5) uncontrolled serum electrolyte imbalance, (6) severely decreased renal function (estimated glomerular filtration rate <30), ( 7) fever (>30°C) or ongoing uncontrolled known infection, (8) bleeding disorders, (9) known contraindication to contrast material, (10) hypersensitivity to nickel, and (11) enrollment in another trial that has not reached the primary endpoint or that interferes with the current study endpoints.…”
Section: Clinical Study Designmentioning
confidence: 99%
See 2 more Smart Citations